Found: 5
Select item for more details and to access through your institution.
Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience.
- Published in:
- Pharmacology Research & Perspectives, 2024, v. 12, n. 1, p. 1, doi. 10.1002/prp2.1167
- By:
- Publication type:
- Article
First reported double drug–drug interaction in a cancer renal patient under everolimus treatment: therapeutic drug monitoring and review of literature.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 16, p. 17112, doi. 10.1002/cam4.6360
- By:
- Publication type:
- Article
DPYD genotyping and 5-fluoropyrimidine toxicity: An overview of systematic reviews protocol.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2024, v. 48, n. 2, p. 79, doi. 10.1016/j.farma.2023.08.009
- By:
- Publication type:
- Article
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 14, p. 3146, doi. 10.3390/jcm10143146
- By:
- Publication type:
- Article